Home
Point72 Asset Management reported a 6.7% stake in Celldex Therapeutics CLDX · 4,464,400 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.7%
- Last report
- First report
- Shares held
- 4,464,400 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Point72 Asset Management
- Event date
- 25/07/02
- Filed
- 25/07/10
First 5%+ report · 6.7% stake
Celldex Therapeutics trades, last 26 weeks
What else happened in Celldex Therapeutics around then
Filed or reported within 30 days of the trade day · 25/06/02~25/08/01Point72 Asset Management's other 5% stake reports
- Point72 Asset Management
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
5% stake
5,687,507 sh
5% stake
Filed 08/20
- Point72 Asset Management
5% stakeRxSight
5% stakeRxSight
RXST
6% stake
2,487,468 sh
6% stake
Filed 08/19
- Point72 Asset Management
5% stakeNeuronetics
5% stakeNeuronetics
STIM
5% stake
3,822,124 sh
5% stake
Filed 08/14
- Point72 Asset Management
5% stakeZepp Health
5% stakeZepp Health
ZEPP
0% stake
0 sh
0% stake
Filed 08/14
- Point72 Asset Management
5% stakeVnet Group
5% stakeVnet Group
VNET
6.6% stake
109,989,366 sh
6.6% stake
Filed 08/14
